Estimation of respiratory syncytial virus-associated hospital admissions in five European countries: a modelling study
This project has received funding from the Innovative Medicines Initiative 2 Joint Undertaking under grant agreement 101034339. This Joint Undertaking receives support from the European Union's Horizon 2020 research and innovation programme and EFPIA.
Authors
- David Gideonse
- Caroline Klint Johannesen (ORCID: https://orcid.org/0000-0001-6503-5632)
- Rolf Kramer (ORCID: https://orcid.org/0000-0002-6095-4338)
- Arantxa Urchueguía-Fornes (ORCID: https://orcid.org/0000-0003-4689-9077)
- Terho Heikkinen (ORCID: https://orcid.org/0000-0001-6504-0116)
- Toni Lehtonen (ORCID: https://orcid.org/0000-0003-2089-2299)
- Ombeline Jollivet
- Richard Osei‐Yeboah (ORCID: https://orcid.org/0000-0003-4622-3691)
- Thea Kølsen Fischer (ORCID: https://orcid.org/0000-0003-4812-980X)
- Michiel van Boven (ORCID: https://orcid.org/0000-0002-0841-2400)
- Harish Nair (ORCID: https://orcid.org/0000-0002-9432-9100)
- Mónica López‐Lacort (ORCID: https://orcid.org/0000-0003-2397-4011)
- Rachel Cohen (ORCID: https://orcid.org/0000-0002-5277-1822)
- Harry Campbell
- María Herrero-Silvestre
Institutions
- Statens Serum Institut (DK)
- University of Copenhagen (DK)
- University of Turku (FI)
- Utrecht University (NL)
- Instituto de Salud Carlos III (ES)
- Turku University Hospital (FI)
- Sanofi (France) (FR)
- University Medical Center Utrecht (NL)
- Finnish Institute for Health and Welfare (FI)
- Zealand University Hospital (DK)
- Fundación para el Fomento de la Investigación Sanitaria y Biomédica de la Comunitat Valenciana (ES)
- National Institute for Public Health and the Environment (NL)
- GlaxoSmithKline (United States) (US)
- University of Edinburgh (GB)
Publication Details
- Journal
- The Lancet Regional Health - Europe
- Published
- 2025-02-05
- DOI
- https://doi.org/10.1016/j.lanepe.2025.101227
- Citations
- 13
- Primary Topic
- Respiratory viral infections research
- Type
- article
- Field-Weighted Citation Impact
- 17.60
Funders
- Pfizer
- GlaxoSmithKline
- Sanofi
- European Federation of Pharmaceutical Industries and Associations
- Novavax
- Innovative Health Initiative
- Imperial College London
- University of Oxford
- European Commission
- Innovative Medicines Initiative
- Fundación para el Fomento de la Investigación Sanitaria y Biomédica de la Comunitat Valenciana
- Horizon 2020 Framework Programme
- Rijksinstituut voor Volksgezondheid en Milieu